Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun 8:14:601-614.
doi: 10.2147/CCID.S267203. eCollection 2021.

Updates and Best Practices in the Management of Facial Erythema

Jameson Loyal  1 , Emily Carr  2 , Rawaa Almukhtar  2 , Mitchel P Goldman  2   3
Affiliations
Review

Updates and Best Practices in the Management of Facial Erythema

Jameson Loyal et al. Clin Cosmet Investig Dermatol. .

Abstract

Facial erythema is a common dermatologic complaint. There are many medical and procedure-based treatments to help reduce the appearance of unwanted facial redness. The authors review a variety of treatment options and techniques to reduce facial erythema and prominent facial veins including topical medical therapies, a variety of lasers, light- and energy-based devices as well as the use of neuromodulators and sclerotherapy. The benefits and potential pitfalls of each procedure modality are also highlighted.

Keywords: energy-based devices; facial redness; facial vessels; flushing; lasers; rosacea.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Before (A) and post one year (B) following 2 PDL treatments for erythema of the nose. Figure courtesy of Dr. Goldman.
Figure 2
Figure 2
Dermal defect present on the alar groove following treatment with LP 1064 nm ND:YAG. Figure courtesy of Dr. Goldman.
Figure 3
Figure 3
Before (A) and after (B) one treatment with IPL for rosacea. Figure courtesy of Dr. Goldman.
Figure 4
Figure 4
Before (A) and after (B) IPL treatment of red nose rosacea with Lumenis One (20 J/cm2, 3.5–3.5 msec). Figure courtesy of Dr. Goldman.
Figure 5
Figure 5
PDT blue light for rosacea, pre-treatment (A), post 1 treatment (B), post two treatments (C). Figure courtesy of Dr. Goldman.
Figure 6
Figure 6
Before (A) and after (B) ALA-PDT for treatment of rosacea with PDL, IPL, and blue/red light. Figure courtesy of Dr. Goldman.
See this image and copyright information in PMC

References

    1. Gether L, Overgaard LK, Egeberg A, et al. Incidence and prevalence of rosacea: a systematic review and meta-analysis. Br J Dermatol. 2018;179(2):282–289. - PubMed
    1. Moustafa F, Lewallen RS, Feldman SR. The psychological impact of rosacea and the influence of current management options. J Am Acad Dermatol. 2014;71(5):973–980. doi:10.1016/j.jaad.2014.05.036 - DOI - PubMed
    1. Del Rosso JQ. Advances in understanding and managing rosacea: part 2: the central role, evaluation, and medical management of diffuse and persistent facial erythema of rosacea. J Clin Aesthet Dermatol. 2012;5(3):26–36. - PMC - PubMed
    1. Jackson JM, Knuckles M, Minni JP, et al. The role of brimonidine tartrate gel in the treatment of rosacea. Clin Cosmet Investig Dermatol. 2015;8:529–538. doi:10.2147/CCID.S58920 - DOI - PMC - PubMed
    1. Chunharas C, Boen M, Alhaddad M, et al. The efficacy of pulsed dye laser pretreated with or without local anesthetic on patients presenting with erythema of face, neck, chest, and extremities. Lasers Surg Med. 2020;52(4):307–314. doi:10.1002/lsm.23146 - DOI - PubMed

LinkOut - more resources